Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry
Guillaume Roger(Assistance Publique – Hôpitaux de Paris), Igor I. Tulevski(Amsterdam University Medical Centers), Petr Widimský(Universidad Americana), Kim Fox(Royal Brompton Hospital), Christian Hassager(University of Copenhagen), Yangsoo Jang(Yonsei University), Ahmad Nizar Jamaluddin, Ian Ford, Grégory Ducrocq, Andrejs Ērglis(Pauls Stradiņš Clinical University Hospital), Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Luigi Tavazzi(Maria Cecilia Hospital), Jassim Al Suwaidi(Hamad Medical Corporation), Assen Goudev(Apple (Israel)), Jérémie Abtan(Lyon 1 Université), Jean‐Claude Tardif(Montreal Heart Institute), Laurent J. Feldman(MACOM (United States)), Upendra Kaul(Batra Hospital and Medical Research Centre), Ibrahim Al Rashdan, Christopher M. Reid(The University of Melbourne), Aleksandras Laucevičius, F. Van Den Branden(IRCCS Humanitas Research Hospital), Yedid Elbez, Marco Alcocer Gamba, Michał Tendera, Nazar Luqman, Iréne Lang(Medical University of Vienna), Jules Mesnier(Hôpital Bichat-Claude-Bernard), Fuad Abdulkader, Neila Sayah(Institut Cardiovasculaire Paris Sud), Panos Vardas(Biomedical Research Foundation of the Academy of Athens), Paul Dorian(St. Michael's Hospital), Béla Merkely(Semmelweis University), Roberto Ferrari(University of Ferrara), Wael Al Mahmeed, Stefan Kääb, Kieran Daly, Kadhim Sulaiman, Dayi Hu, Fernando Sökn, Luis Machado César, Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 8
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k